Literature DB >> 11268993

Resection of hepatocellular carcinoma.

D Franco1, V Usatoff.   

Abstract

The majority of hepatocellular carcinoma occurs in patients with liver cirrhosis. Although the tumors are often discovered at an early stage during surveillance of these patients, the underlying cirrhosis renders the surgery more difficult and exposes the patients to higher rates of postoperative morbidity and mortality than occurs in other types of liver surgery. Over the past 20 years surgeons have developed new surgical procedures and techniques to firstly reduce the unnecessary resection of liver parenchyma and to decrease intraoperative blood loss. Better patient selection and understanding of prognostic factors will hopefully result in a further decrease in operative risk and postoperative recurrence. Adjuvant chemotherapy may prove effective in reducing the postoperative recurrence but at this stage surgery still remains as the best treatment for patients with recurrent tumor which is accessible to resection.

Entities:  

Mesh:

Year:  2001        PMID: 11268993

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

2.  Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.

Authors:  Xiao-Hua Zheng; Yong-Song Guan; Xiang-Ping Zhou; Juan Huang; Long Sun; Xiao Li; Yuan Liu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.

Authors:  Guan-Tarn Huang; Po-Huang Lee; Yuk-Ming Tsang; Ming-Yang Lai; Pei-Ming Yang; Rey-Heng Hu; Pei-Jer Chen; Jia-Horng Kao; Jin-Chuan Sheu; Cha-Ze Lee; Ding-Shinn Chen
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

Review 4.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 5.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Surgery for large primary liver cancer more than 10 cm in diameter.

Authors:  Xin-Da Zhou; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Lun-Xiu Qin; Bo-Heng Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-30       Impact factor: 4.553

7.  Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer.

Authors:  Xue-Ping Zhou; Zhi-Wei Quan; Wen-Ming Cong; Ning Yang; Hai-Bin Zhang; Shu-Hui Zhang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

8.  Computational and In Vitro Analysis of Plumbagin's Molecular Mechanism for the Treatment of Hepatocellular Carcinoma.

Authors:  Yanfei Wei; Yuning Lin; Wanjun Chen; Shasha Liu; Lijie Jin; Delun Huang
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.